These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 26117478)

  • 21. DOTS-Plus for multidrug-resistant tuberculosis in the Philippines: global assistance urgently needed.
    Tupasi TE; Quelapio MI; Orillaza RB; Alcantara C; Mira NR; Abeleda MR; Belen VT; Arnisto NM; Rivera AB; Grimaldo ER; Derilo JO; Dimarucut W; Arabit M; Urboda D
    Tuberculosis (Edinb); 2003; 83(1-3):52-8. PubMed ID: 12758189
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Community-based care vs. centralised hospitalisation for MDR-TB patients, KwaZulu-Natal, South Africa.
    Loveday M; Wallengren K; Brust J; Roberts J; Voce A; Margot B; Ngozo J; Master I; Cassell G; Padayatchi N
    Int J Tuberc Lung Dis; 2015 Feb; 19(2):163-71. PubMed ID: 25574914
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Trends of anti-tuberculosis drug resistance pattern in new cases and previously treated cases of extrapulmonary tuberculosis cases in referral hospitals in northern India.
    Maurya AK; Kant S; Nag VL; Kushwaha RA; Dhole TN
    J Postgrad Med; 2012; 58(3):185-9. PubMed ID: 23023350
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Social support a key factor for adherence to multidrug-resistant tuberculosis treatment.
    Deshmukh RD; Dhande DJ; Sachdeva KS; Sreenivas AN; Kumar AMV; Parmar M
    Indian J Tuberc; 2018 Jan; 65(1):41-47. PubMed ID: 29332647
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prescription patterns and treatment outcomes of MDR-TB patients treated within and outside the National Tuberculosis Programme in Pham Ngoc Thach hospital, Viet Nam.
    Hoa NB; Khanh PH; Chinh NV; Hennig CM
    Trop Med Int Health; 2014 Sep; 19(9):1076-81. PubMed ID: 24995611
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Current status of multidrug resistant tuberculosis in a tertiary care hospital of East Delhi.
    Sagar T; Singh NP; Kashyap B; Kaur IR
    J Postgrad Med; 2013; 59(3):173-6. PubMed ID: 24029192
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Patients with MDR-TB on domiciliary care in programmatic settings in Myanmar: Effect of a support package on preventing early deaths.
    Wai PP; Shewade HD; Kyaw NTT; Kyaw KWY; Thein S; Si Thu A; Oo MM; Htwe PS; Tun MMT; Win Maung HM; Soe KT; Aung ST
    PLoS One; 2017; 12(12):e0187223. PubMed ID: 29261669
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Factors predicting treatment success in multi-drug resistant tuberculosis patients treated under programmatic conditions.
    Janmeja AK; Aggarwal D; Dhillon R
    Indian J Tuberc; 2018 Apr; 65(2):135-139. PubMed ID: 29579427
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genetic mutations associated with rifampicin and isoniazid resistance in MDR-TB patients in North-West India.
    Kumar P; Kumar P; Balooni V; Singh S
    Int J Tuberc Lung Dis; 2015 Apr; 19(4):434-9. PubMed ID: 25859999
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High effectiveness of a 12-month regimen for MDR-TB patients in Cameroon.
    Kuaban C; Noeske J; Rieder HL; Aït-Khaled N; Abena Foe JL; Trébucq A
    Int J Tuberc Lung Dis; 2015 May; 19(5):517-24. PubMed ID: 25868018
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment outcomes for HIV-uninfected patients with multidrug-resistant and extensively drug-resistant tuberculosis.
    Kwon YS; Kim YH; Suh GY; Chung MP; Kim H; Kwon OJ; Choi YS; Kim K; Kim J; Shim YM; Koh WJ
    Clin Infect Dis; 2008 Aug; 47(4):496-502. PubMed ID: 18611154
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Multidrug resistant tuberculosis in Romania in the last years (2004-2007)--an extremely important social phenomenon].
    Marica C; Didilescu C; Chiotan D; Galie N; Tănăsescu M; Popescu-Hagen M; Popa M
    Pneumologia; 2008; 57(4):195-200. PubMed ID: 19186681
    [TBL] [Abstract][Full Text] [Related]  

  • 33. "Home is where the patient is": a qualitative analysis of a patient-centred model of care for multi-drug resistant tuberculosis.
    Horter S; Stringer B; Reynolds L; Shoaib M; Kasozi S; Casas EC; Verputten M; du Cros P
    BMC Health Serv Res; 2014 Feb; 14():81. PubMed ID: 24559177
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Management and treatment outcomes of MDR-TB: results from a setting with high rates of drug resistance.
    Ahmad N; Javaid A; Basit A; Afridi AK; Khan MA; Ahmad I; Sulaiman SA; Khan AH
    Int J Tuberc Lung Dis; 2015 Sep; 19(9):1109-14, i-ii. PubMed ID: 26260834
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Loss-To-Follow-Up on Multidrug Resistant Tuberculosis Treatment in Gujarat, India: The WHEN and WHO of It.
    Shringarpure KS; Isaakidis P; Sagili KD; Baxi RK
    PLoS One; 2015; 10(7):e0132543. PubMed ID: 26167891
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Where there is hope: a qualitative study examining patients' adherence to multi-drug resistant tuberculosis treatment in Karakalpakstan, Uzbekistan.
    Horter S; Stringer B; Greig J; Amangeldiev A; Tillashaikhov MN; Parpieva N; Tigay Z; du Cros P
    BMC Infect Dis; 2016 Jul; 16():362. PubMed ID: 27465783
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Management of multi-drug resistant tuberculosis: practitioner's view point.
    Prasad R
    Indian J Tuberc; 2007 Jan; 54(1):3-11. PubMed ID: 17455417
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Changing patterns and trends of multidrug-resistant tuberculosis at referral centre in Northern India: a 4-year experience.
    Maurya AK; Singh AK; Kumar M; Umrao J; Kant S; Nag VL; Kushwaha RA; Dhole TN
    Indian J Med Microbiol; 2013; 31(1):40-6. PubMed ID: 23508428
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Converging risk factors but no association between HIV infection and multidrug-resistant tuberculosis in Kazakhstan.
    van den Hof S; Tursynbayeva A; Abildaev T; Adenov M; Pak S; Bekembayeva G; Ismailov S
    Int J Tuberc Lung Dis; 2013 Apr; 17(4):526-31. PubMed ID: 23485387
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Low treatment initiation rates among multidrug-resistant tuberculosis patients in Gauteng, South Africa, 2011.
    Ebonwu JI; Tint KS; Ihekweazu C
    Int J Tuberc Lung Dis; 2013 Aug; 17(8):1043-8. PubMed ID: 23827028
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.